Visualitza per autor "MUÑOZ COUSELO, EVA"
Ara mostrant els elements 1-20 d 25
-
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials
Bareche, Yacine; Abbas-Aghababazadeh, Farnoosh; Lo Giacco, Deborah; Martin Casado, Agatha; Saavedra Gadea, Omar; Berche, Roger; Mirallas, Oriol; Jimenez, Jose; Valverde Morales, Claudia Maria; Díez García, Marc; Hernando-Calvo, Alberto; Vila-Casadesús, Maria; Gonzalez Medina, Alberto; Brana, Irene; Vieito , Maria; fasani, roberta; Mancuso, Francesco Mattia; Saoudi Gonzalez, Nadia; Suárez, Cristina; Elez, Elena; Capdevila Castillon, Jaume; OAKNIN, ANA; Saura Manich, Cristina; Macarulla, Teresa; Carles, Joan; FELIP, ENRIQUETA; Nuciforo, Paolo; Seoane, Joan; Tabernero, Josep; GARRALDA, Elena; Vivancos, Ana; MUÑOZ COUSELO, EVA; Dienstmann, Rodrigo (Elsevier, 2023-10-13) -
A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy
Weiss, Sarah; Sznol, Mario; shaheen, montaser; Berciano Guerrero, Miguel Angel; MUÑOZ COUSELO, EVA; Rodriguez-Abreu, Delvys (American Association for Cancer Research, 2024-01-01) -
Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience
Oleas, Diana; Bolufer Cardona, Monica; Agraz Pamplona, Irene; Felip Font, Enriqueta; Gabaldon Dominguez, Alejandra; Bury, Roxana; Espinel Garuz, María Eugenia; Serón Micas, Daniel; García Carro, Clara; Soler Romeo, Maria Jose; Muñoz Couselo, Eva (Oxford University Press, 2021-05) -
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
Weber, Jeffrey; Schadendorf, Dirk; Del Vecchio, Michele; Atkinson, Victoria; Schenker, M.; Larkin, James; Muñoz Couselo, Eva (American Society of Clinical Oncology, 2023-01-20) -
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results
Diab, Adi; Gogas, Helen; Sandhu, Shahneen ; Long, Georgina; ASCIERTO, PAOLO ANTONIO; Larkin, James; MUÑOZ COUSELO, EVA (American Society of Clinical Oncology, 2023-10-20) -
BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
McGrail Fernández, Kimberley Anne; Granado Martinez, Paula; Esteve Puig, Rosaura; Garcia Ortega, Sara; Ding, Yuxin; Sanchez-Redondo Campos, Sara; Ferrer Fábrega, Berta; Hernandez Losa, Javier; Canals Suris, Francesc; Pérez, Mileidys; García-Patos Briones, Vicente; Recio Conde, Juan Angel; Muñoz Couselo, Eva (Nature Portfolio, 2022-11-19) -
Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)
Puertolas, Teresa; Riveiro Barciela, Maria del Mar; Paredes, Roger; Gonzalez-Cao, Maria; Ortiz Velez, Carolina; Muñoz Couselo, Eva (BMJ, 2021-03) -
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
mandala, mario; Lorigan, Paul; Sergi, Maria Chiara; Benannoune, Naima; Serra, Patricio; Vitale, Maria Grazia; MUÑOZ COUSELO, EVA (Elsevier, 2024-01-19) -
Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy
Ferrer Fábrega, Berta; González-Cruz, Carlos; MUÑOZ COUSELO, EVA; Ortiz Velez, Carolina; Garcia-Patos Briones, Vicente; Ferrandiz-Pulido, Carla (Elsevier, 2024-03-01) -
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119
Cortes, Javier; Winer, Eric; Lipatov, Oleg; Im, Seock-Ah; Gonçalves, Anthony; MUÑOZ COUSELO, EVA (Wiley, 2024-05) -
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
Garcia-Alvarez, Alejandro; Ortiz Velez, Carolina; Muñoz Couselo, Eva (Dove Medical Press, 2021-06-09) -
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
Álamo, Mª del Carmen; Ochenduszko, Sebastian; Crespo, Guillermo; Corral, Mónica; Oramas, Juana; Sancho, Pilar; Muñoz Couselo, Eva (Dove Medical Press, 2021-11-27) -
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
Clingan, Philip; Ladwa, Rahul; Brungs, Daniel; Harris, Dean Laurence; McGrath, Margaret; Arnold, Susan; MUÑOZ COUSELO, EVA (BMJ, 2023-10) -
Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate)
Nebot, Noelia; Won, Christina S.; Lee, Dung-Yang; Gasal, Eduard; Bouillaud, Emmanuel; Moreno, Victor; Muñoz Couselo, Eva (Wiley, 2021-09) -
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
Lozano Rabella, Maria; Garcia-Garijo, Andrea; Palomero, Jara; Yuste-Estevanez, Anna; Erhard, Florian; Farriol-Duran, Roc; Ochoa de Olza, Maria; Matos, Ignacio ; Canals, Francesc; Brana, Irene; Gros, Alena; GARRALDA, Elena; MUÑOZ COUSELO, EVA (American Association for Cancer Research, 2023-06-13) -
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Bratland, Åse; MORTIER, Laurent; Roshdy, Osama; González, Rene; Schachter, Jacob; MUÑOZ COUSELO, EVA (Springer, 2023-12) -
Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis
Amor López, Ana; Mazariegos, Marina S.; Capuano, Alessandra; Ximénez-Embún, Pilar; Hergueta-Redondo, Marta; Recio Conde, Juan Angel; Muñoz Couselo, Eva (MDPI, 2021-07-09) -
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Sabaté Gallego, Mònica; Pérez Esquirol, Eulalia; García Doladé, Núria; Vidal Guitart, Xavier; Farriols Danes, Anna Maria; Felip Font, Enriqueta; Braña Garcia, Irene; Carles Galceran, Joan; Morales Barrera, Rafael; Agustí Escasany, Maria Antònia; Carreras Soler, Maria Josep; Muñoz Couselo, Eva (Frontiers Media, 2022-08-22) -
Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study
Clavero-Rovira, Laia; Gómez Tomás, Álvaro; Bassas Freixas, Patricia; Bodet, Domingo; Ferrer Fábrega, Berta; Garcia-Patos Briones, Vicente; MUÑOZ COUSELO, EVA; PEREZ BENAVENTE, ASUNCION; Ferrandiz-Pulido, Carla; Hernandez-Losa, Javier (MDPI, 2024-01-03) -
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure
Spreafico, Anna; Irmisch, Anja; Bessa, Juliana; Au-Yeung, George; MUÑOZ COUSELO, EVA; Bechter, Oliver (Frontiers Media, 2024-03-21)